|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | |
| C12N 15/13 | |||
| C12N 15/85 | |||
| C12N 5/10 | |||
| A61K 39/395 | |||
| A61P 19/02 | |||
| A61P 37/00 | |||
| A61P 25/00 |
| (11) | Number of the document | 1590369 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04703964.9 |
| Date of filing the European patent application | 2004-01-21 | |
| (97) | Date of publication of the European application | 2005-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/000019 |
| Date | 2004-01-21 |
| (87) | Number | WO 2004/067568 |
| Date | 2004-08-12 |
| (30) | Number | Date | Country code |
| 442798 P | 2003-01-24 | US |
| (72) |
DICKINSON, Craig, Duane, US
VASSEROT, Alain, Philippe, US
WATKINS, Jeffry, Dean, US
LU, Jirong, US
|
| (73) |
Applied Molecular Evolution, Inc.,
3520 Dunhill Street, San Diego, CA 92121,
US
|
| (54) | HUMAN IL-1 BETA ANTAGONISTS |
| HUMAN IL-1 BETA ANTAGONISTS |